Ezeh Kosisochukwu J, Ezeudemba Obiora
Internal Medicine, Jersey City Medical Center, Jersey City, USA.
Internal Medicine, St. Vincent's Medical Center, Bridgeport, USA.
Cureus. 2021 Jul 15;13(7):e16412. doi: 10.7759/cureus.16412. eCollection 2021 Jul.
Hyperlipidemia is the most common modifiable cause of atherosclerotic cardiovascular disease. Our understanding of managing hyperlipidemia has led us to the concept of the inverse correlation of low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein (non-HDL) cholesterol with the advent of a major adverse cardiovascular event. This review will provide an overview of lipids and their metabolism. Additionally, it will focus on hyperlipidemia and approaches to its management.
高脂血症是动脉粥样硬化性心血管疾病最常见的可改变病因。随着主要不良心血管事件的出现，我们对高脂血症管理的认识使我们形成了低密度脂蛋白胆固醇（LDL-C）和非高密度脂蛋白（non-HDL）胆固醇呈负相关的概念。本综述将概述脂质及其代谢。此外，它将重点关注高脂血症及其管理方法。
